BG Medicine this week announced that its board of directors has appointed Eric Bouvier as the firm's new president and CEO. The appointment became effective Jan. 9. Bouvier brings more than a decade of experience in the cardiovascular and molecular diagnostic markets. Previously, Bouvier was head of bioMerieux's immunoassay business.
Pieter Muntendam, who has served as president and CEO of BG Medicine for the past six years will now be the company's executive VP and chief medical officer.